𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Conversion From Calcineurin Inhibitors to Everolimus With Low-Dose Cyclosporine in Renal Transplant Recipients With Squamous Cell Carcinoma of the Skin

✍ Scribed by Caroti, L.; Zanazzi, M.; Paudice, N.; Tsalouchos, A.; Carta, P.; Larti, A.; Pimpinelli, N.; Moscarelli, L.; Salvadori, M.; Bertoni, E.


Book ID
119382634
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
86 KB
Volume
44
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Improvement of renal function after the
✍ Javier F. CastroagudΓ­n; Esther Molina; Rafael Romero; Esteban Otero; Santiago To πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 1 views

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro

A randomized controlled trial of late co
✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 307 KB πŸ‘ 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin